X-37 Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14.5M

  • Investors
  • 4

X-37 General Information

Description

Developer of a drug development platform designed to facilitate the discovery of various medicines for patients. The company's platform uses artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against high-value pharmaceutical targets, enabling the healthcare sector to discover and develop medicines faster.

Contact Information

Website
x37.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 Oyster Point Boulevard
  • Suite 202
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 400 Oyster Point Boulevard
  • Suite 202
  • South San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

X-37 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 14-Nov-2019 $14.5M Completed Pre-Clinical Trials
1. Seed Round 01-Dec-2018 Completed Startup
To view X-37’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

X-37 Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug development platform designed to facilitate the discovery of various medicines for patients. The com
Drug Discovery
South San Francisco, CA
2 As of 2024

Toronto, Canada
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

X-37 Competitors (49)

One of X-37’s 49 competitors is Deep Genomics, a Venture Capital-Backed company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Deep Genomics Venture Capital-Backed Toronto, Canada
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom
Valo Venture Capital-Backed Lexington, MA
BioBlocks Corporate Backed or Acquired Hamilton, NJ
insitro Venture Capital-Backed South San Francisco, CA
You’re viewing 5 of 49 competitors. Get the full list »

X-37 Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X-37 Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alpha Intelligence Capital Venture Capital Minority
BlackPine Group Venture Capital Minority
Hemi Ventures Venture Capital Minority
DCVC Bio Venture Capital Minority
To view X-37’s complete investors history, request access »

X-37 FAQs

  • When was X-37 founded?

    X-37 was founded in 2018.

  • Where is X-37 headquartered?

    X-37 is headquartered in South San Francisco, CA.

  • What is the size of X-37?

    X-37 has 2 total employees.

  • What industry is X-37 in?

    X-37’s primary industry is Drug Discovery.

  • Is X-37 a private or public company?

    X-37 is a Private company.

  • What is X-37’s current revenue?

    The current revenue for X-37 is .

  • How much funding has X-37 raised over time?

    X-37 has raised $14.5M.

  • Who are X-37’s investors?

    Alpha Intelligence Capital, BlackPine Group, Hemi Ventures, and DCVC Bio have invested in X-37.

  • Who are X-37’s competitors?

    Deep Genomics, Sphere Fluidics, Valo, BioBlocks, and insitro are some of the 49 competitors of X-37.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »